Skip to main content
Trusted advisor to healthcare practitioners · Est. 2016

Devices · For physicians

Eufoton Lasemar 1500 Submental Contouring Protocols

Published October 24, 2026

Laser Wavelength
1470 nm

Diode wavelength engineered for high absorption in both water and lipid chromophores within the subdermal plane.

Typical Fiber Diameter
200–300 microns

Standard single-use micro-optical fiber calibers selected for facial and submental interstitial navigation.

Primary Cost Drivers
Capital device & single-use fiber kits

Operational economics center on fixed equipment acquisition and predictable per-patient disposable fiber consumables.

Eufoton Lasemar 1500 protocols for submental contouring and tightening utilize a 1470 nm diode laser delivered via single-use interstitial micro-optical fibers to induce selective photothermolysis of subdermal adipose tissue and simultaneous dermal neocollagenesis. By targeting the chromophores of both water and fat within the superficial hypodermis, the procedure achieves structural remodeling and skin retraction under local anesthesia without incisions or sutures. Clinical execution relies on precise anatomical mapping, plane-specific fiber navigation, and real-time thermal monitoring to protect adjacent neurovascular structures.

Mechanism of Action: The 1470 nm Wavelength in the Submental Plane

For physicians evaluating minimally invasive options to bridge the gap between non-invasive transdermal energy devices and surgical neck lifts, the Endolift technique performed on the Eufoton Lasemar 1500 platform offers a targeted interstitial approach. Unlike transdermal radiofrequency or high-intensity focused ultrasound (HIFU), which must pass through the epidermis to heat deep tissues, the Lasemar 1500 delivers laser energy directly into the subdermal space via bare, flexible quartz micro-optical fibers (typically 200 to 300 microns in diameter for facial and submental indications).

The 1470 nm wavelength resides at an absorption peak where it exhibits high affinity for both water and lipid chromophores. When delivered interstitially, this wavelength produces two distinct physiological effects:

  1. Selective Emulsification of Adipocytes: When directed into the superficial submental fat pad (pre-platysmal fat), the thermal energy disrupts adipocyte membranes, converting solid lipid deposits into an oily emulsion. Depending on the clinical objective and volume, this liquefied fraction is either cleared naturally via the lymphatic system over subsequent weeks or gently expressed through the fiber entry point.
  2. Fibroseptal Network Contraction and Neocollagenesis: When the fiber is navigated in the more superficial subdermal plane, the photothermal effect heats the water-rich extracellular matrix and the fibroseptal network (FSN). This causes immediate contraction of existing collagen fibrils and initiates a wound-healing cascade that stimulates fibroblasts to deposit new Type I and Type III collagen over a three-to-six-month remodeling phase.

Clinical Assessment and Patient Selection

Success with Eufoton Lasemar 1500 protocols for submental contouring and tightening depends heavily on pre-procedural stratification. The modality is not a replacement for platysmaplasty or extensive rhytidectomy in patients with severe tissue redundancy. Rather, it is optimized for patients presenting with mild-to-moderate skin laxity, blunting of the cervicomental angle, and localized pre-platysmal adiposity.

During the physical examination, the treating clinician should differentiate between pre-platysmal and sub-platysmal fat by having the patient grimace or contract the platysma muscle. The interstitial laser fiber must remain strictly superficial to the platysma; sub-platysmal fat and prominent digastric muscles cannot be safely or effectively addressed with this technique.

Pre-Procedural Clinical Checklist

  • Anatomical Boundary Mapping: With the patient seated upright, mark the inferior border of the mandible, the anterior borders of the sternocleidomastoid muscles, the thyroid cartilage, and the specific vectors of submental adiposity and laxity.
  • Danger Zone Identification: Clearly delineate the course of the marginal mandibular nerve (particularly where it crosses the inferior border of the mandible near the facial vessels) and the external jugular veins. These zones require superficial-only passage or complete avoidance depending on tissue thickness.
  • Tissue Pinch Test: Assess dermal thickness and subcutaneous fat volume. Patients with very thin skin and minimal subcutaneous fat require lower-energy, tightening-focused parameters using a smaller-caliber fiber (e.g., 200 microns) to prevent dermal burns or contour irregularities.
  • Contraindication Screening: Rule out active cutaneous infections, history of keloid scarring in the neck, severe systemic autoimmune conditions affecting collagen synthesis, pregnancy, and unrealistic expectations regarding surgical-grade lifting.
  • Photographic Documentation: Capture standardized baseline photographs in frontal, 45-degree oblique, and 90-degree lateral views with neutral head positioning to objectively track long-term tissue retraction.

Standardizing the Submental Protocol Workflow

While specific joule settings and pulse modes are determined by the treating physician based on patient anatomy and manufacturer clinical training, the procedural workflow follows a structured sequence designed to maximize safety and uniformity of energy distribution.

1. Anesthesia and Entry Preparation

The procedure is performed in an outpatient exam room under sterile or clean field conditions. Because the micro-optical fiber enters the skin directly without a cannula or trocar, no scalpel incisions are required. Anesthesia typically consists of local infiltration at the designated entry points (commonly one submental midline point and two post-auricular or sub-lobular points) followed by either light subcutaneous infiltration of buffered lidocaine or cooled air analgesia. Excessive tumescent fluid volume is generally avoided or kept minimal in pure tightening protocols, as excessive extracellular water can alter the laser-tissue interaction and obscure visual contour endpoints.

2. Fiber Insertion and Fanning Vectors

The disposable micro-optical fiber is threaded through a specialized handpiece and inserted directly through the epidermis at an acute angle. Once in the subcutaneous plane, the clinician observes the red aiming beam transilluminating through the skin. The brightness and sharpness of this transilluminated spot serve as a continuous depth gauge: a bright, sharply defined red dot indicates a superficial subdermal position, whereas a diffuse, dim glow indicates the fiber is too deep (approaching or below the platysma).

The fiber is advanced and retracted in a retrograde linear fanning pattern across the mapped aesthetic units. Laser emission is typically activated primarily during the retrograde (withdrawal) stroke or continuous rhythmic movement to prevent thermal pooling at the distal tip of the fiber.

3. Dual-Plane Execution (Lipolysis vs. Tightening)

In patients requiring both volume reduction and skin retraction, protocols are often divided into two phases:

  • Deep Subcutaneous Phase (Lipolysis): The fiber is navigated within the pre-platysmal fat compartment to deliver cumulative thermal energy sufficient to emulsify adipocytes.
  • Superficial Subdermal Phase (Tightening): The fiber is redirected to the immediate subdermal plane, moving more rapidly in a cross-hatched vector pattern to stimulate the dermis and fibroseptal network.

Throughout both phases, the clinician's non-dominant hand—or an external thermal camera—monitors epidermal surface temperature. Achieving an appropriate surface thermal endpoint without exceeding safe epidermal thresholds is critical to avoiding blister formation or post-inflammatory hyperpigmentation.

4. Post-Procedural Management and Synergistic Modalities

Following energy delivery, the entry sites require no sutures and are dressed with simple topical ointment. Patients typically experience mild-to-moderate edema, transient erythema, and occasional bruising that resolves over several days to two weeks. Some clinicians incorporate adjunctive regenerative modalities—such as topical biologics applied after fractional resurfacing or staged microneedling—to further support dermal matrix quality during the remodeling window.

Operational Considerations for Practice Managers

While the physician evaluates clinical efficacy and safety, the practice manager or clinical director must assess how the Eufoton Lasemar 1500 integrates into existing aesthetics and dermatology service lines.

  • Consumable Cost Tracking: The primary per-procedure variable cost is the single-use, sterile micro-optical fiber kit, alongside standard supplies such as local anesthetics, syringes, and sterile drapes. Because the fibers are disposable and calibrated for single-patient use, inventory management and per-case cost accounting are straightforward.
  • Room Footprint and Portability: The Lasemar 1500 is a compact, tabletop diode system that requires standard electrical power and no external cooling water hookups. It can be moved easily between treatment rooms without dedicated facility build-outs.
  • Staffing and Delegation: Depending on state medical board regulations (such as Texas Medical Board rules governing laser delegation), interstitial laser procedures may be restricted to physicians or specifically credentialed advanced practice providers. Practice managers must verify state-specific scope-of-practice compliance before scheduling.
  • Multi-Indication Utility: Beyond submental contouring, the 1470 nm platform supports protocols for lower face jowling, periorbital tightening, and small-area body contouring (such as periumbilical laxity or above-the-knee skin redundancy), allowing practices to amortize capital acquisition costs across multiple procedural codes.

What This Means for Your Practice

Integrating Eufoton Lasemar 1500 protocols for submental contouring and tightening allows a clinical practice to capture the large cohort of patients who are dissatisfied with transdermal tightening results but unwilling to undergo surgical neck lifts or excisional liposuction.

Concrete Next Actions:

  1. Audit Current Patient Demand: Review consultation logs over the past two quarters to identify how many patients declined surgical referral or expressed dissatisfaction with non-invasive submental treatments.
  2. Verify Regulatory Scope: Confirm which licensed providers within your practice are authorized to perform interstitial laser procedures under your state's medical board statutes.
  3. Evaluate Hardware and Training Support: Assess the full specifications of the Eufoton Lasemar 1500 within our devices portfolio and verify the onboarding clinical training pathways required to standardize protocols across your provider team.

To review clinical training opportunities, fiber consumable structures, and device specifications for your clinic, contact Dallas Regenerative Solutions to schedule a consultation with our clinical device specialists.

Frequently asked questions

How is depth controlled during an interstitial submental laser protocol?
Depth is monitored visually using the device's integrated red aiming beam, which transilluminates through the skin. A sharp, bright light spot indicates the fiber tip is in the superficial subdermal plane, while a dull or absent light indicates the fiber has passed too deeply toward the platysma muscle. Clinicians also use tactile feedback and manual tissue stabilization with the non-dominant hand to maintain a consistent plane.
What is the typical treatment cadence for submental contouring with the Lasemar 1500?
In most clinical workflows, Eufoton Lasemar 1500 submental protocols are performed as a single-session intervention rather than a multi-session weekly series. Because neocollagenesis and lymphatic clearance of emulsified lipids occur gradually, final structural remodeling is typically evaluated at three to six months post-procedure. If secondary refinement is clinically indicated, a touch-up session is generally deferred until this remodeling phase is complete.
How does the 1470 nm interstitial laser differ from submental cryolipolysis or deoxycholic acid injections?
Cryolipolysis and deoxycholic acid injections focus solely on adipocyte destruction and do not actively tighten the overlying dermis, which can occasionally unmask skin laxity once volume is reduced. The 1470 nm interstitial diode laser addresses both compartments simultaneously by emulsifying pre-platysmal fat and delivering controlled thermal energy to the fibroseptal network and dermis to stimulate tissue retraction.
What anatomical structures represent the primary safety boundaries in the submental region?
The primary structure requiring protection is the marginal mandibular branch of the facial nerve, which courses near the inferior border of the mandible and becomes superficial anteriorly. Additionally, clinicians must remain strictly superficial to the platysma muscle to avoid deep vascular structures, the submandibular glands, and the anterior jugular veins. Proper tumescent or local anesthesia infiltration and continuous superficial transillumination help safeguard these zones.
Are the micro-optical fibers reusable across multiple submental procedures?
No, the 200-micron and 300-micron optical fibers used for facial and submental interstitial protocols are sterile, single-use consumables. During laser emission and mechanical passage through fibrotic tissue, the distal quartz tip experiences thermal and physical degradation that alters energy transmission if reused. Using a fresh, calibrated fiber for each patient ensures predictable energy delivery and strict infection control.

Bring regenerative medicine into your practice.

Talk with our team about biologics, devices, or an AI-powered peptide protocol tailored to your patients.

Request Consultation →